- Home
- FGEN vs LITB Comparison
FGEN vs LITB Comparison
Compare FGEN & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- LITB
- Stock Information
- Founded
- FGEN 1993
- LITB 2007
- Country
- FGEN United States
- LITB Singapore
- Employees
- FGEN N/A
- LITB N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- LITB Catalog/Specialty Distribution
- Sector
- FGEN Health Care
- LITB Consumer Discretionary
- Exchange
- FGEN Nasdaq
- LITB Nasdaq
- Market Cap
- FGEN 34.5M
- LITB N/A
- IPO Year
- FGEN 2014
- LITB N/A
- Fundamental
- Price
- FGEN $0.43
- LITB $1.00
- Analyst Decision
- FGEN Strong Buy
- LITB
- Analyst Count
- FGEN 1
- LITB 0
- Target Price
- FGEN $10.00
- LITB N/A
- AVG Volume (30 Days)
- FGEN 8.2M
- LITB 21.6K
- Earning Date
- FGEN 05-05-2025
- LITB 03-24-2025
- Dividend Yield
- FGEN N/A
- LITB N/A
- EPS Growth
- FGEN N/A
- LITB N/A
- EPS
- FGEN N/A
- LITB N/A
- Revenue
- FGEN $180,015,000.00
- LITB $333,093,000.00
- Revenue This Year
- FGEN $22.77
- LITB N/A
- Revenue Next Year
- FGEN N/A
- LITB N/A
- P/E Ratio
- FGEN N/A
- LITB N/A
- Revenue Growth
- FGEN 16.15
- LITB N/A
- 52 Week Low
- FGEN $0.18
- LITB $0.91
- 52 Week High
- FGEN $2.80
- LITB $6.00
- Technical
- Relative Strength Index (RSI)
- FGEN 46.25
- LITB 41.05
- Support Level
- FGEN $0.36
- LITB $0.92
- Resistance Level
- FGEN $0.49
- LITB $1.05
- Average True Range (ATR)
- FGEN 0.06
- LITB 0.05
- MACD
- FGEN -0.00
- LITB 0.01
- Stochastic Oscillator
- FGEN 29.46
- LITB 61.54
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.